Trial intelligence / Profile preview

Topical Phenytoin Plus Fractional CO2 Laser for Atrophic Post-Acne Scars

NCT06942468Phase 4Not yet recruiting

Sponsor
Assiut University
Start
Jul 2025
Primary completion
Jul 2026
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of phenytoin in atrophic acne scars (2 arms), sponsored by Assiut University. Primary endpoint: Quantitative Global Acne Scarring Score. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

phenytoin
03

Conditions

atrophic acne scars

Beyond the preview

Go deeper on NCT06942468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06942468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call